恩典生命科技控股有限公司(已委任联席临时清盘人)(仅作重组用途)于2026年3月2日发布2026年2月股份变动月报表。报告期内公司法定股本为3,000,000,000股，面值每股0.01港元，合计3,000万港元；已发行股份维持在1,500,000,000股，无新增发行、购回或注销股份。
根据公告，公司普通股在2月期间并无发生增减变动，库藏股数亦保持为零。公司现行购股权计划可供行使股份数为1.5亿股，本月内未有新增行使或失效情况。
截至2026年2月28日，公司的已发行股本总额较上月底无变化，仍保持在15亿股，法定股本总额则维持在3,000万港元。公司同时确认符合香港联交所相关上市规则及其他法律规定。公告由公司秘书陈坤签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.